Ramky Infrastructure Signs INR 3,000 Crore Concession for Pharma Park
Filing Summary
Ramky Infrastructure Limited has executed a concession agreement with Maharashtra Industrial Development Corporation for a High-Tech Pharmaceutical Park at Dighi Port Industrial Area, Maharashtra. The project, valued at approximately INR 3,000 crore, will be developed by Maha Integrated Life Sciences City Limited, a wholly owned subsidiary of Ramky Infrastructure. The project will span 1,000 hectares and operate under a 95-year concession period. The development will include industrial zones, commercial areas, and shared facilities. This agreement increases Ramky Infrastructure’s order book to INR 13,500 crore.
Ramky Infrastructure Limited has announced the execution of a concession agreement with the Maharashtra Industrial Development Corporation for the development of a High-Tech Pharmaceutical Park at the Dighi Port Industrial Area in Raigad district, Maharashtra. The agreement involves Maha Integrated Life Sciences City Limited, a wholly owned subsidiary of Ramky Infrastructure. The project will be developed on a Public-Private Partnership basis under the Design, Build, Finance, Operate and Transfer model.
The estimated project cost is approximately INR 3,000 crore. The revenue model includes land lease premiums, lease rentals, development charges, maintenance charges for common infrastructure, and operational charges for utilities and shared facilities. The concession period is set for 95 years, including a five-year construction phase. This project will contribute to Ramky Infrastructure’s order book, which now stands at approximately INR 13,500 crore.
The High-Tech Pharmaceutical Park will cover approximately 1,000 hectares and will include industrial zones, commercial areas, common infrastructure, utilities, internal road networks, and designated open spaces. The project aims to establish an integrated life sciences manufacturing ecosystem, providing infrastructure and shared facilities for pharmaceutical, biotechnology, and life sciences companies. Key elements include integrated infrastructure, advanced utilities, research and development centers, incubation hubs, and technology transfer platforms.
The project is designed to support high standards of environmental safety, regulatory compliance, and sustainable industrial operations. Under the terms of the concession agreement, Maha Integrated Life Sciences City Limited will be responsible for the development, operation, maintenance, and management of the project throughout the concession period.
The project will be implemented over a 95-year period, with the construction phase expected to be completed in five years. The development will be managed by Maha Integrated Life Sciences City Limited, with oversight from the Maharashtra Industrial Development Corporation. This initiative is part of a broader strategy to enhance industrial infrastructure in the region and attract investments into the pharmaceutical and life sciences sectors.
Maharashtra Industrial Development Corporation is a key player in industrial development within the state, focusing on creating industrial infrastructure and facilitating investment in various sectors. The corporation’s collaboration with Ramky Infrastructure aims to boost the pharmaceutical and life sciences industries in Maharashtra.
Ramky Infrastructure Limited is a prominent infrastructure development company within the Ramky Group, established in 1994. The company specializes in industrial infrastructure, water and wastewater treatment, roads, bridges, and urban infrastructure development. Ramky Infrastructure operates across India and international markets, guided by ISO certifications in quality, environmental, and occupational health and safety management systems.